Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II–IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016)
Keyword(s):
2006 ◽
Vol 2006
◽
pp. 435-436
2010 ◽
Vol 119
(3)
◽
pp. 444-450
◽
2007 ◽
Vol 5
(4)
◽
pp. 356
◽
Keyword(s):
2008 ◽
Vol 26
(15_suppl)
◽
pp. 5529-5529
◽
Keyword(s):
2014 ◽
Vol 32
(15_suppl)
◽
pp. 5507-5507
◽
Keyword(s):
2005 ◽
Vol 23
(21)
◽
pp. 4626-4633
◽
2015 ◽
Vol 33
(10)
◽
pp. 1180-1185
◽
2009 ◽
Vol 27
(28)
◽
pp. 4649-4655
◽